Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Haptoglobin Hp1 Variant Does Not Associate with Small Vessel Disease.

Lempiäinen J, Ijäs P, Niiranen TJ, Kaste M, Karhunen PJ, Lindsberg PJ, Erkinjuntti T, Melkas S.

Brain Sci. 2019 Dec 28;10(1). pii: E18. doi: 10.3390/brainsci10010018.

2.

Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups.

Lo JW, Crawford JD, Desmond DW, Godefroy O, Jokinen H, Mahinrad S, Bae HJ, Lim JS, Köhler S, Douven E, Staals J, Chen C, Xu X, Chong EJ, Akinyemi RO, Kalaria RN, Ogunniyi A, Barbay M, Roussel M, Lee BC, Srikanth VK, Moran C, Kandiah N, Chander RJ, Sabayan B, Jukema JW, Melkas S, Erkinjuntti T, Brodaty H, Bordet R, Bombois S, Hénon H, Lipnicki DM, Kochan NA, Sachdev PS; Stroke and Cognition (STROKOG) Collaboration.

Neurology. 2019 Dec 10;93(24):e2257-e2271. doi: 10.1212/WNL.0000000000008612. Epub 2019 Nov 11.

3.

Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline.

Jokinen H, Koikkalainen J, Laakso HM, Melkas S, Nieminen T, Brander A, Korvenoja A, Rueckert D, Barkhof F, Scheltens P, Schmidt R, Fazekas F, Madureira S, Verdelho A, Wallin A, Wahlund LO, Waldemar G, Chabriat H, Hennerici M, O'Brien J, Inzitari D, Lötjönen J, Pantoni L, Erkinjuntti T.

Stroke. 2020 Jan;51(1):170-178. doi: 10.1161/STROKEAHA.119.026170. Epub 2019 Nov 8.

4.

Automatically computed rating scales from MRI for patients with cognitive disorders.

Koikkalainen JR, Rhodius-Meester HFM, Frederiksen KS, Bruun M, Hasselbalch SG, Baroni M, Mecocci P, Vanninen R, Remes A, Soininen H, van Gils M, van der Flier WM, Scheltens P, Barkhof F, Erkinjuntti T, Lötjönen JMP; Alzheimer’s Disease Neuroimaging Initiative.

Eur Radiol. 2019 Sep;29(9):4937-4947. doi: 10.1007/s00330-019-06067-1. Epub 2019 Feb 22.

PMID:
30796570
5.

Executive function subdomains are associated with post-stroke functional outcome and permanent institutionalization.

Laakso HM, Hietanen M, Melkas S, Sibolt G, Curtze S, Virta M, Ylikoski R, Pohjasvaara T, Kaste M, Erkinjuntti T, Jokinen H.

Eur J Neurol. 2019 Mar;26(3):546-552. doi: 10.1111/ene.13854. Epub 2018 Dec 10.

PMID:
30414288
6.

Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study.

Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, O'Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG.

Alzheimers Dement. 2018 Mar;14(3):280-292. doi: 10.1016/j.jalz.2017.09.007. Epub 2017 Oct 19.

PMID:
29055812
7.

Haptoglobin Hp2 Variant Promotes Premature Cardiovascular Death in Stroke Survivors.

Ijäs P, Melkas S, Saksi J, Jula A, Jauhiainen M, Oksala N, Pohjasvaara T, Kaste M, Karhunen PJ, Lindsberg P, Erkinjuntti T.

Stroke. 2017 Jun;48(6):1463-1469. doi: 10.1161/STROKEAHA.116.015683. Epub 2017 May 9.

PMID:
28487337
8.

STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.

Sachdev PS, Lo JW, Crawford JD, Mellon L, Hickey A, Williams D, Bordet R, Mendyk AM, Gelé P, Deplanque D, Bae HJ, Lim JS, Brodtmann A, Werden E, Cumming T, Köhler S, Verhey FR, Dong YH, Tan HH, Chen C, Xin X, Kalaria RN, Allan LM, Akinyemi RO, Ogunniyi A, Klimkowicz-Mrowiec A, Dichgans M, Wollenweber FA, Zietemann V, Hoffmann M, Desmond DW, Linden T, Blomstrand C, Fagerberg B, Skoog I, Godefroy O, Barbay M, Roussel M, Lee BC, Yu KH, Wardlaw J, Makin SJ, Doubal FN, Chappell FM, Srikanth VK, Thrift AG, Donnan GA, Kandiah N, Chander RJ, Lin X, Cordonnier C, Moulin S, Rossi C, Sabayan B, Stott DJ, Jukema JW, Melkas S, Jokinen H, Erkinjuntti T, Mok VC, Wong A, Lam BY, Leys D, Hénon H, Bombois S, Lipnicki DM, Kochan NA; STROKOG.

Alzheimers Dement (Amst). 2016 Nov 18;7:11-23. doi: 10.1016/j.dadm.2016.10.006. eCollection 2017.

9.

The Vascular Impairment of Cognition Classification Consensus Study.

Skrobot OA, O'Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG.

Alzheimers Dement. 2017 Jun;13(6):624-633. doi: 10.1016/j.jalz.2016.10.007. Epub 2016 Dec 10.

PMID:
27960092
10.

Cognitive reserve moderates long-term cognitive and functional outcome in cerebral small vessel disease.

Jokinen H, Melkas S, Madureira S, Verdelho A, Ferro JM, Fazekas F, Schmidt R, Scheltens P, Barkhof F, Wardlaw JM, Inzitari D, Pantoni L, Erkinjuntti T.

J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1296-1302. doi: 10.1136/jnnp-2016-313914. Epub 2016 Oct 7.

PMID:
27951523
11.

A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort.

Skrobot OA, McKnight AJ, Passmore PA, Seripa D, Mecocci P, Panza F, Kalaria R, Wilcock G, Munafò M, Erkinjuntti T, Karhunen P, Pessi T, Martiskainen M, Love S; Genetic and Environmental Risk for Alzheimer’s disease Consortium (GERAD1), Kehoe PG.

J Alzheimers Dis. 2016 Jun 15;53(3):981-9. doi: 10.3233/JAD-150862.

PMID:
27314523
12.

Early-Stage White Matter Lesions Detected by Multispectral MRI Segmentation Predict Progressive Cognitive Decline.

Jokinen H, Gonçalves N, Vigário R, Lipsanen J, Fazekas F, Schmidt R, Barkhof F, Madureira S, Verdelho A, Inzitari D, Pantoni L, Erkinjuntti T; LADIS Study Group.

Front Neurosci. 2015 Dec 2;9:455. doi: 10.3389/fnins.2015.00455. eCollection 2015.

13.

Severe cerebral white matter lesions in ischemic stroke patients are associated with less time spent at home and early institutionalization.

Sibolt G, Curtze S, Melkas S, Pohjasvaara T, Kaste M, Karhunen PJ, Oksala NK, Erkinjuntti T.

Int J Stroke. 2015 Dec;10(8):1192-6. doi: 10.1111/ijs.12578. Epub 2015 Oct 21.

PMID:
26487377
14.

Post-stroke cognitive impairment is common even after successful clinical recovery.

Jokinen H, Melkas S, Ylikoski R, Pohjasvaara T, Kaste M, Erkinjuntti T, Hietanen M.

Eur J Neurol. 2015 Sep;22(9):1288-94. doi: 10.1111/ene.12743. Epub 2015 Jun 4.

PMID:
26040251
15.

[Investments of research and treatment of brain diseases will pay of time].

Lindsberg PJ, Castrén E, Korkeila J, Alho H, Erkinjuntti T, Isometsä E, Kalso E, Marttunen M, Pihko H, Tienari P, Wartiovaara A, Jäkälä P, Kälviäinen R, Soininen H, Tiihonen J, Karlsson H, Rinne J, Roine RO, Elovaara I, Tamminen T, Ohman J, Majamaa K, Hari R.

Duodecim. 2014;130(17):1721-30. Review. Finnish.

PMID:
25272783
16.

White matter lesions are associated with hospital admissions because of hip-fractures and trauma after ischemic stroke.

Sibolt G, Curtze S, Melkas S, Pohjasvaara T, Kaste M, Karhunen PJ, Oksala NK, Strandberg T, Erkinjuntti T.

Stroke. 2014 Oct;45(10):2948-51. doi: 10.1161/STROKEAHA.114.006116. Epub 2014 Aug 28.

PMID:
25169948
17.

Preoperative white matter lesions are independent predictors of long-term survival after internal carotid endarterectomy.

Oksala N, Jaroma M, Pienimäki JP, Kuorilehto T, Vänttinen T, Lehtomäki A, Suominen VP, Dastidar P, Mäkinen K, Erkinjuntti T, Salenius JP.

Cerebrovasc Dis Extra. 2014 Jun 7;4(2):122-31. doi: 10.1159/000363128. eCollection 2014 Jan.

18.

Βeta-fibrinogen gene promoter A -455 allele associated with poor longterm survival among 55-71 years old Caucasian women in Finnish stroke cohort.

Martiskainen M, Oksala N, Pohjasvaara T, Kaste M, Oksala A, Karhunen PJ, Erkinjuntti T.

BMC Neurol. 2014 Jun 22;14:137. doi: 10.1186/1471-2377-14-137.

19.

Neurological abnormalities predict disability: the LADIS (Leukoaraiosis And DISability) study.

Poggesi A, Gouw A, van der Flier W, Pracucci G, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Blahak C, Langhorne P, O'Brien J, Schmidt R, Visser MC, Wahlund LO, Waldemar G, Wallin A, Scheltens P, Inzitari D, Pantoni L.

J Neurol. 2014 Jun;261(6):1160-9. doi: 10.1007/s00415-014-7332-9. Epub 2014 Apr 11.

PMID:
24723116
20.

Post-stroke depression and depression-executive dysfunction syndrome are associated with recurrence of ischaemic stroke.

Sibolt G, Curtze S, Melkas S, Pohjasvaara T, Kaste M, Karhunen PJ, Oksala NK, Vataja R, Erkinjuntti T.

Cerebrovasc Dis. 2013;36(5-6):336-43. doi: 10.1159/000355145. Epub 2013 Oct 30.

PMID:
24193249
21.

Relationships between white matter hyperintensities, cerebral amyloid angiopathy and dementia in a population-based sample of the oldest old.

Tanskanen M, Kalaria RN, Notkola IL, Mäkelä M, Polvikoski T, Myllykangas L, Sulkava R, Kalimo H, Paetau A, Scheltens P, Barkhof F, van Straaten E, Erkinjuntti T.

Curr Alzheimer Res. 2013 Dec;10(10):1090-7.

PMID:
24156259
22.

Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study.

Hooshmand B, Polvikoski T, Kivipelto M, Tanskanen M, Myllykangas L, Erkinjuntti T, Mäkelä M, Oinas M, Paetau A, Scheltens P, van Straaten EC, Sulkava R, Solomon A.

Brain. 2013 Sep;136(Pt 9):2707-16. doi: 10.1093/brain/awt206.

23.

Shape abnormalities of the caudate nucleus correlate with poorer gait and balance: results from a subset of the LADIS study.

Macfarlane MD, Looi JC, Walterfang M, Spulber G, Velakoulis D, Styner M, Crisby M, Orndahl E, Erkinjuntti T, Waldemar G, Garde E, Hennerici MG, Bäzner H, Blahak C, Wallin A, Wahlund LO; LADIS Study Group.

Am J Geriatr Psychiatry. 2015 Jan;23(1):59-71.e1. doi: 10.1016/j.jagp.2013.04.011. Epub 2013 Aug 1.

24.

Executive dysfunction correlates with caudate nucleus atrophy in patients with white matter changes on MRI: a subset of LADIS.

Macfarlane MD, Looi JC, Walterfang M, Spulber G, Velakoulis D, Crisby M, Orndahl E, Erkinjuntti T, Garde E, Waldemar G, Wallin A, Wahlund LO; LADIS Study Group.

Psychiatry Res. 2013 Oct 30;214(1):16-23. doi: 10.1016/j.pscychresns.2013.05.010. Epub 2013 Aug 2.

PMID:
23916538
25.

Deterioration of gait and balance over time: the effects of age-related white matter change--the LADIS study.

Kreisel SH, Blahak C, Bäzner H, Inzitari D, Pantoni L, Poggesi A, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Hennerici MG.

Cerebrovasc Dis. 2013;35(6):544-53. doi: 10.1159/000350725. Epub 2013 Jul 6.

PMID:
23838682
26.

Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study.

Verdelho A, Madureira S, Moleiro C, Ferro JM, O'Brien JT, Poggesi A, Pantoni L, Fazekas F, Scheltens P, Waldemar G, Wallin A, Erkinjuntti T, Inzitari D; LADIS Study.

J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1250-4. doi: 10.1136/jnnp-2012-304191. Epub 2013 May 28.

PMID:
23715914
27.

[Posterior variant of Alzheimer's disease and other atypical symptom pictures].

Remes AM, Vanninen R, Jokinen H, Hallikainen M, Erkinjuntti T.

Duodecim. 2013;129(3):244-50. Review. Finnish.

PMID:
23457775
28.

Diffusion changes predict cognitive and functional outcome: the LADIS study.

Jokinen H, Schmidt R, Ropele S, Fazekas F, Gouw AA, Barkhof F, Scheltens P, Madureira S, Verdelho A, Ferro JM, Wallin A, Poggesi A, Inzitari D, Pantoni L, Erkinjuntti T; LADIS Study Group.

Ann Neurol. 2013 May;73(5):576-83. doi: 10.1002/ana.23802. Epub 2013 Feb 19.

PMID:
23423951
29.

Poststroke dementia is associated with recurrent ischaemic stroke.

Sibolt G, Curtze S, Melkas S, Putaala J, Pohjasvaara T, Kaste M, Karhunen PJ, Oksala NK, Erkinjuntti T.

J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):722-6. doi: 10.1136/jnnp-2012-304084. Epub 2013 Feb 16.

PMID:
23418214
30.

Confirmatory factor analysis of the Neuropsychological Assessment Battery of the LADIS study: a longitudinal analysis.

Moleiro C, Madureira S, Verdelho A, Ferro JM, Poggesi A, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Pantoni L, Salvadori E, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D; LADIS Study.

J Clin Exp Neuropsychol. 2013;35(3):269-78. doi: 10.1080/13803395.2013.770822. Epub 2013 Feb 11.

PMID:
23398381
31.

Cerebral white matter changes are associated with abnormalities on neurological examination in non-disabled elderly: the LADIS study.

Poggesi A, Gouw A, van der Flier W, Pracucci G, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O'Brien JT, Visser MC, Wahlund LO, Waldemar G, Wallin A, Scheltens P, Inzitari D, Pantoni L.

J Neurol. 2013 Apr;260(4):1014-21. doi: 10.1007/s00415-012-6748-3. Epub 2012 Nov 20.

PMID:
23180181
32.

Physical activity prevents progression for cognitive impairment and vascular dementia: results from the LADIS (Leukoaraiosis and Disability) study.

Verdelho A, Madureira S, Ferro JM, Baezner H, Blahak C, Poggesi A, Hennerici M, Pantoni L, Fazekas F, Scheltens P, Waldemar G, Wallin A, Erkinjuntti T, Inzitari D; LADIS Study.

Stroke. 2012 Dec;43(12):3331-5. doi: 10.1161/STROKEAHA.112.661793. Epub 2012 Nov 1.

PMID:
23117721
33.

Geriatric syndromes--vascular disorders?

Strandberg TE, Pitkälä KH, Tilvis RS, O'Neill D, Erkinjuntti TJ.

Ann Med. 2013 May;45(3):265-73. doi: 10.3109/07853890.2012.727022. Epub 2012 Oct 16. Review.

PMID:
23072364
34.

Extensive white matter changes predict stroke recurrence up to 5 years after a first-ever ischemic stroke.

Melkas S, Sibolt G, Oksala NK, Putaala J, Pohjasvaara T, Kaste M, Karhunen PJ, Erkinjuntti T.

Cerebrovasc Dis. 2012;34(3):191-8. doi: 10.1159/000341404. Epub 2012 Sep 19.

PMID:
23006549
35.

Educational history is an independent predictor of cognitive deficits and long-term survival in postacute patients with mild to moderate ischemic stroke.

Ojala-Oksala J, Jokinen H, Kopsi V, Lehtonen K, Luukkonen L, Paukkunen A, Seeck L, Melkas S, Pohjasvaara T, Karhunen P, Hietanen M, Erkinjuntti T, Oksala N.

Stroke. 2012 Nov;43(11):2931-5. doi: 10.1161/STROKEAHA.112.667618. Epub 2012 Aug 30.

PMID:
22935400
36.

EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia.

Sorbi S, Hort J, Erkinjuntti T, Fladby T, Gainotti G, Gurvit H, Nacmias B, Pasquier F, Popescu BO, Rektorova I, Religa D, Rusina R, Rossor M, Schmidt R, Stefanova E, Warren JD, Scheltens P; EFNS Scientist Panel on Dementia and Cognitive Neurology.

Eur J Neurol. 2012 Sep;19(9):1159-79. doi: 10.1111/j.1468-1331.2012.03784.x.

PMID:
22891773
37.

White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations.

Schmidt R, Berghold A, Jokinen H, Gouw AA, van der Flier WM, Barkhof F, Scheltens P, Petrovic K, Madureira S, Verdelho A, Ferro JM, Waldemar G, Wallin A, Wahlund LO, Poggesi A, Pantoni L, Inzitari D, Fazekas F, Erkinjuntti T; LADIS Study Group.

Stroke. 2012 Oct;43(10):2643-7. Epub 2012 Aug 9.

PMID:
22879094
38.

Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study.

Firbank MJ, Teodorczuk A, van der Flier WM, Gouw AA, Wallin A, Erkinjuntti T, Inzitari D, Wahlund LO, Pantoni L, Poggesi A, Pracucci G, Langhorne P, O'Brien JT; LADIS group.

Br J Psychiatry. 2012 Jul;201(1):40-5. doi: 10.1192/bjp.bp.111.098897. Epub 2012 May 24.

PMID:
22626634
39.

Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study.

Jokinen H, Lipsanen J, Schmidt R, Fazekas F, Gouw AA, van der Flier WM, Barkhof F, Madureira S, Verdelho A, Ferro JM, Wallin A, Pantoni L, Inzitari D, Erkinjuntti T; LADIS Study Group.

Neurology. 2012 May 29;78(22):1785-92. doi: 10.1212/WNL.0b013e3182583070. Epub 2012 May 16.

PMID:
22592361
40.

Callosal tissue loss parallels subtle decline in psychomotor speed. a longitudinal quantitative MRI study. The LADIS Study.

Jokinen H, Frederiksen KS, Garde E, Skimminge A, Siebner H, Waldemar G, Ylikoski R, Madureira S, Verdelho A, van Straaten EC, Barkhof F, Fazekas F, Schmidt R, Pantoni L, Inzitari D, Erkinjuntti T.

Neuropsychologia. 2012 Jun;50(7):1650-5. doi: 10.1016/j.neuropsychologia.2012.03.020. Epub 2012 Apr 2.

PMID:
22497753
41.

[Brain imaging of patients with memory disorders].

Vanninen R, Mäntylä R, Salonen O, Valanne L, Rinne J, Erkinjuntti T.

Duodecim. 2011;127(24):2615-26. Review. Finnish.

PMID:
22320104
42.

2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease?

The LADIS Study Group, Poggesi A, Pantoni L, Inzitari D, Fazekas F, Ferro J, O'Brien J, Hennerici M, Scheltens P, Erkinjuntti T, Visser M, Langhorne P, Chabriat H, Waldemar G, Wallin A, Wahlund A.

Cerebrovasc Dis. 2011;32(6):577-588. Epub 2011 Dec 1.

43.

Corpus callosum tissue loss and development of motor and global cognitive impairment: the LADIS study.

Frederiksen KS, Garde E, Skimminge A, Barkhof F, Scheltens P, van Straaten EC, Fazekas F, Baezner H, Verdelho A, Ferro JM, Erkinjuntti T, Jokinen H, Wahlund LO, O'Brien JT, Basile AM, Pantoni L, Inzitari D, Waldemar G.

Dement Geriatr Cogn Disord. 2011;32(4):279-86. doi: 10.1159/000334949. Epub 2012 Jan 19.

44.

Self-perceived memory complaints predict progression to Alzheimer disease. The LADIS study.

Verdelho A, Madureira S, Moleiro C, Santos CO, Ferro JM, Erkinjuntti T, Poggesi A, Pantoni L, Fazekas F, Scheltens P, Waldemar G, Wallin A, Inzitari D; LADIS Study.

J Alzheimers Dis. 2011;27(3):491-8. doi: 10.3233/JAD-2011-110494.

PMID:
21841255
45.

[The treatment pathway of a memory disorder patient].

Suhonen J, Rahkonen T, Juva K, Pitkälä K, Voutilainen P, Erkinjuntti T.

Duodecim. 2011;127(11):1107-16. Review. Finnish.

PMID:
21755802
46.

Heterogeneity in age-related white matter changes.

Schmidt R, Schmidt H, Haybaeck J, Loitfelder M, Weis S, Cavalieri M, Seiler S, Enzinger C, Ropele S, Erkinjuntti T, Pantoni L, Scheltens P, Fazekas F, Jellinger K.

Acta Neuropathol. 2011 Aug;122(2):171-85. doi: 10.1007/s00401-011-0851-x. Epub 2011 Jun 25. Review.

PMID:
21706175
47.

Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort.

Ryberg C, Rostrup E, Paulson OB, Barkhof F, Scheltens P, van Straaten EC, van der Flier WM, Fazekas F, Schmidt R, Ferro JM, Baezner H, Erkinjuntti T, Jokinen H, Wahlund LO, Poggesi A, Pantoni L, Inzitari D, Waldemar G; LADIS study group.

J Neurol Sci. 2011 Aug 15;307(1-2):100-5. doi: 10.1016/j.jns.2011.05.002. Epub 2011 May 31.

PMID:
21621224
48.

Post-stroke delirium in relation to dementia and long-term mortality.

Melkas S, Laurila JV, Vataja R, Oksala N, Jokinen H, Pohjasvaara T, Leppävuori A, Kaste M, Karhunen PJ, Erkinjuntti T.

Int J Geriatr Psychiatry. 2012 Apr;27(4):401-8. doi: 10.1002/gps.2733. Epub 2011 May 10.

PMID:
21560162
49.

Incident lacunes influence cognitive decline: the LADIS study.

Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten EC, van der Flier WM, Barkhof F, Scheltens P, Fazekas F, Schmidt R, Verdelho A, Ferro JM, Pantoni L, Inzitari D, Erkinjuntti T; LADIS Study Group.

Neurology. 2011 May 31;76(22):1872-8. doi: 10.1212/WNL.0b013e31821d752f. Epub 2011 May 4.

PMID:
21543730
50.

Small-vessel disease relates to poor poststroke survival in a 12-year follow-up.

Melkas S, Putaala J, Oksala NK, Pohjasvaara T, Oksala A, Kaste M, Karhunen PJ, Erkinjuntti T.

Neurology. 2011 Feb 22;76(8):734-9. doi: 10.1212/WNL.0b013e31820db666.

PMID:
21339501

Supplemental Content

Loading ...
Support Center